System and method for distinguishing between hypoglycemia and hyperglycemia using an implantable medical device
First Claim
1. A method for use with an implantable medical device for detecting one of hypoglycemia and hyperglycemia within a patient in which the device is implanted, said method comprising:
- tracking with the implantable medical device, rates of change of ventricular repolarization amplitudes and at least one of atrial depolarization amplitudes and ventricular depolarization amplitudes and ventricular repolarization amplitudes;
detecting with the implantable medical device, an onset of hyperglycemia upon detecting a rapid increase in at least one of the rate of change of atrial depolarization amplitudes and ventricular depolarization amplitudes; and
detecting with the implantable medical device, an onset of hypoglycemia upon detecting a rapid increase in the rate of change of ventricular repolarization amplitudes.
0 Assignments
0 Petitions
Accused Products
Abstract
Techniques are described for detecting and distinguishing among ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. In one technique, these conditions are detected and distinguished based on an analysis of: the interval between the QRS complex and the peak of a T-wave (QTmax), the interval between the QRS complex and the end of a T-wave (QTend), alone or in combination with a change in ST segment elevation. By exploiting QTmax and QTend in combination with ST segment elevation, changes in ST segment elevation caused by hypo/hyperglycemia can be properly distinguished from changes caused by cardiac ischemia. In another technique, hyperglycemia and hypoglycemia are predicted, detected and/or distinguished from one another based on an analysis of the amplitudes of P-waves, QRS-complexes and T-waves within the IEGM. Appropriate warning signals are delivered and therapy is automatically adjusted.
0 Citations
10 Claims
-
1. A method for use with an implantable medical device for detecting one of hypoglycemia and hyperglycemia within a patient in which the device is implanted, said method comprising:
-
tracking with the implantable medical device, rates of change of ventricular repolarization amplitudes and at least one of atrial depolarization amplitudes and ventricular depolarization amplitudes and ventricular repolarization amplitudes; detecting with the implantable medical device, an onset of hyperglycemia upon detecting a rapid increase in at least one of the rate of change of atrial depolarization amplitudes and ventricular depolarization amplitudes; and detecting with the implantable medical device, an onset of hypoglycemia upon detecting a rapid increase in the rate of change of ventricular repolarization amplitudes. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. An implantable medical device comprising:
-
a detector operative to detect ventricular repolarization amplitudes and at least one of atrial depolarization amplitudes and ventricular depolarization amplitudes; and a processor operative to; track rates of change of ventricular repolarization amplitudes and at least one of atrial depolarization amplitudes and ventricular depolarization amplitudes; detect an onset of hyperglycemia upon detecting a rapid increase in at least one of the rate of change of atrial depolarization amplitudes and ventricular depolarization amplitudes; and detect an onset of hypoglycemia upon detecting a rapid increase in the rate of change of ventricular repolarization amplitudes.
-
Specification